Hiroko Yagihara

Effect of Tyrosine Kinase Inhibition by Imatinib Mesylate on Mast Cell Tumors in Dogs

Mayu Isotani, Nobuhiro Ishida, M. Tominaga et al. · Journal of Veterinary Internal Medicine · 2008 · 105 citations · Full text

Mutations in the fifth immunoglobulin‐like domain of kit are common and potentially sensitive to imatinib mesylate in feline mast cell tumours

Mayu Isotani, Osamu Yamada, Joshua L. Lachowicz et al. · British Journal of Haematology · 2009 · 62 citations

Cancer Research, Immunogenetics, Signal Transduction +13

Chronic sleep fragmentation exacerbates amyloid β deposition in Alzheimer’s disease model mice

Eiko N. Minakawa, Koyomi Miyazaki, Kazushi Maruo et al. · Neuroscience Letters · 2017 · 60 citations

Sleep Disorders, Sleep, Neurodegenerative Diseases +12

Identification of a c-kit exon 8 internal tandem duplication in a feline mast cell tumor case and its favorable response to the tyrosine kinase inhibitor imatinib mesylate

Mayu Isotani, Kyoichi Tamura, Hiroko Yagihara et al. · Veterinary Immunology and Immunopathology · 2006 · 58 citations

Chromatin, Medicine, Pathology +6

Development of the polymerase chain reaction assay based on the canine genome database for detection of monoclonality in B cell lymphoma

Kyoichi Tamura, Hiroko Yagihara, Mayu Isotani et al. · Veterinary Immunology and Immunopathology · 2005 · 48 citations

Hematological Malignancy, Polymerase Chain Reaction, Canine Genome Database +10